Mental Health  |  OST Drug Issues Pathway - Dosing and Maintenance Treatment




Mental Health

OST Drug Issues Pathway - Dosing and Maintenance Treatment

Initial dose is usually 2-4mg buprenorphine/naloxone on the first day with subsequent doses titrated upwards against withdrawal symptoms in 2-4mg increments, to a maximum daily dose of 32mg. For most patients, good compliance can be achieved in the range 8-16mg daily. Unlike methadone there are no buprenorphine/naloxone 'fast metabolizers' and once-daily dosing is appropriate for the vast majority of patients.

For some patients who have had a suitable period of stabilisation at a regular daily dose, the frequency of dosing may be reduced to alternate-days at twice the titrated daily dose, with no reduction in clinical effect. For example, a patient stable at 8mg buprenorphine/naloxone daily may be prescribed 16mg on alternate days. However, the maximum dose given on any one day should never exceed 32mg and alternate-day dosing should only be done with the full informed consent of the patient.



Last updated : Thursday, January 09, 2020
Next review date : Friday, January 08,2021


Disclaimer: This site is intended to be flexible and frequently updated. While every effort has been made to ensure accuracy, all information should be verified.